7Cook D. Ventilator-associated pneumonia:Parspectives on the burden of illness [ J ]. Intensive Care Med, 2002 ( Suppl) :31 - 37.
8Morehead R S, Pinto S J. Ventilator-associated pneumonia [ J]. Architecture Intemet Med 2000(13) :1926 - 1936.
9Dennesen PJ, Ven AJ, Kessels AG, et al. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia [ J ], Am J Respir Crit Care Med, 2001 (6) : 1371 - 1375.
10Safdar N, Crnich C J, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention [ J ]. Respir Care, 2005 (50) :725 -741.
6Tsukayama DT, Loon HJ, Cartwright C, et al. The evolution of pseu-domonas Aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial[J]. Inter J Antimicrob a- gents,2004,24(4) :339-345.
7Goossens H. MYSTIC Progam:summary of European data from 1997 to 2000[J]. Diagn Micohiol Infect Dis, 2001,41 (4): 183-189.
8Kiiru J, Butaye Goddeeris BM, et al. Analysts for prevalence and physical linkages amongst integrons, ISEcp 1, ISCR1, Tn21 and Tn7 encountered in Escherichia eoli strains from hospitalized and non-hospitalized patients in Kenya during a 19 year period(1992- 2011)[J]. BMC Microbiol,2013,13(109) :1471-1476.
